NEW ORLEANS, Nov. 9 – A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD) ...

The study was performed using data from 109 patients who were on DA-therapy at the time of device implantation. The control group consisted of 318 patients of which 104 patients (32.7%) were on ASA.

Improvements in optimal medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) have helped reduce the risk of sudden cardiac death (SCD)—in the modern era, though, just ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a ...

FALLS CHURCH, VA — A new meta-analysis supports the value of an implantable cardioverter defibrillator (ICD) for primary prevention in patients with ischemic and nonischemic cardiomyopathy [1]. When ...

(HealthDay News) – A simple model may be used to predict risk for in-hospital adverse events among patients receiving an implantable cardioverter defibrillator (ICD), according to research published ...

On February 15, 2018, CMS released a final policy decision updating the national coverage determination (NCD) governing implantable cardioverter defibrillator (ICD) implantation for Medicare ...

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, ...

Implantable cardioverter defibrillator (ICD) information on YouTube is of low and highly-variable quality, according to research presented at the American College of Cardiology (ACC) Quality Summit ...

Rome, Italy - 28 August, 2016: Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual ...